# Robinhood Markets, Inc.: financial statements, quarterly

HOOD · Nasdaq · CIK 1783879 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hood.md) · [Financials](/companies/hood/financials.md) · [Filings](/companies/hood/filings.md) · [Insiders](/companies/hood/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hood/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [471 d](/filings/0001783879-26-000029.md) | [618](/filings/0001783879-25-000145.md) | [682](/filings/0001783879-25-000251.md) | [637](/filings/0001783879-25-000310.md) | [1,014 d](/filings/0001783879-26-000029.md) | [927](/filings/0001783879-26-000062.md) | [989](/filings/0001783879-26-000114.md) | [1,274](/filings/0001783879-26-000167.md) | [1,283 d](/filings/0001783879-26-000029.md) | [1,067](/filings/0001783879-26-000062.md) | [1,308](/filings/0001783879-26-000114.md) | [1,424](/filings/0001783879-26-000167.md) |
| Income tax | $m | [(1.0) d](/filings/0001783879-26-000029.md) | [5.0](/filings/0001783879-25-000145.md) | [3.0](/filings/0001783879-25-000251.md) | [3.0](/filings/0001783879-25-000310.md) | [(358) d](/filings/0001783879-26-000029.md) | [35.0](/filings/0001783879-26-000062.md) | [56.0](/filings/0001783879-26-000114.md) | [78.0](/filings/0001783879-26-000167.md) | [56.0 d](/filings/0001783879-26-000029.md) | [65.0](/filings/0001783879-26-000062.md) | [136](/filings/0001783879-26-000114.md) | [149](/filings/0001783879-26-000167.md) |
| Net income | $m | [30.0 d](/filings/0001783879-26-000029.md) | [157](/filings/0001783879-25-000145.md) | [188](/filings/0001783879-25-000251.md) | [150](/filings/0001783879-25-000310.md) | [916 d](/filings/0001783879-26-000029.md) | [336](/filings/0001783879-26-000062.md) | [386](/filings/0001783879-26-000114.md) | [556](/filings/0001783879-26-000167.md) | [605 d](/filings/0001783879-26-000029.md) | [350](/filings/0001783879-26-000062.md) | [561](/filings/0001783879-26-000114.md) | [468](/filings/0001783879-26-000167.md) |
| Diluted EPS | $ per share | not reported | [0.18](/filings/0001783879-25-000145.md) | [0.21](/filings/0001783879-25-000251.md) | [0.17](/filings/0001783879-25-000310.md) | not reported | [0.37](/filings/0001783879-26-000062.md) | [0.42](/filings/0001783879-26-000114.md) | [0.61](/filings/0001783879-26-000167.md) | not reported | [0.38](/filings/0001783879-26-000062.md) | [0.62](/filings/0001783879-26-000114.md) | [0.51](/filings/0001783879-26-000167.md) |
| Basic EPS | $ per share | not reported | [0.18](/filings/0001783879-25-000145.md) | [0.21](/filings/0001783879-25-000251.md) | [0.17](/filings/0001783879-25-000310.md) | not reported | [0.38](/filings/0001783879-26-000062.md) | [0.44](/filings/0001783879-26-000114.md) | [0.63](/filings/0001783879-26-000167.md) | not reported | [0.39](/filings/0001783879-26-000062.md) | [0.62](/filings/0001783879-26-000114.md) | [0.52](/filings/0001783879-26-000167.md) |

- Revenue: us-gaap:Revenues
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [4.8](/filings/0001783879-26-000029.md) | [4.7](/filings/0001783879-25-000145.md) | [4.5](/filings/0001783879-25-000251.md) | [4.6](/filings/0001783879-25-000310.md) | [4.3](/filings/0001783879-26-000029.md) | [4.4](/filings/0001783879-26-000062.md) | [4.2](/filings/0001783879-26-000114.md) | [4.3](/filings/0001783879-26-000167.md) | [4.3](/filings/0001783879-26-000167.md) | [5.0](/filings/0001783879-26-000062.md) | [5.4](/filings/0001783879-26-000114.md) | [5.8](/filings/0001783879-26-000167.md) |
| Current assets | $bn | [17.1](/filings/0001783879-25-000049.md) | [45.5](/filings/0001783879-24-000145.md) | [40.7](/filings/0001783879-24-000233.md) | [42.6](/filings/0001783879-24-000296.md) | [25.1](/filings/0001783879-26-000029.md) | [26.2](/filings/0001783879-25-000145.md) | [33.8](/filings/0001783879-25-000251.md) | [40.0](/filings/0001783879-25-000310.md) | [36.3](/filings/0001783879-26-000167.md) | [43.4](/filings/0001783879-26-000062.md) | [54.5](/filings/0001783879-26-000114.md) | [56.3](/filings/0001783879-26-000167.md) |
| Total assets | $bn | [17.6](/filings/0001783879-25-000049.md) | [46.1](/filings/0001783879-24-000145.md) | [41.3](/filings/0001783879-24-000233.md) | [43.2](/filings/0001783879-24-000296.md) | [26.2](/filings/0001783879-26-000029.md) | [27.5](/filings/0001783879-25-000145.md) | [35.3](/filings/0001783879-25-000251.md) | [41.5](/filings/0001783879-25-000310.md) | [38.1](/filings/0001783879-26-000167.md) | [45.5](/filings/0001783879-26-000062.md) | [56.6](/filings/0001783879-26-000114.md) | [58.3](/filings/0001783879-26-000167.md) |
| Current liabilities | $bn | [10.8](/filings/0001783879-25-000049.md) | [39.1](/filings/0001783879-24-000145.md) | [34.1](/filings/0001783879-24-000233.md) | [36.0](/filings/0001783879-24-000296.md) | [18.1](/filings/0001783879-26-000029.md) | [19.4](/filings/0001783879-25-000145.md) | [27.1](/filings/0001783879-25-000251.md) | [32.8](/filings/0001783879-25-000310.md) | [28.8](/filings/0001783879-26-000167.md) | [35.6](/filings/0001783879-26-000062.md) | [44.6](/filings/0001783879-26-000114.md) | [45.2](/filings/0001783879-26-000167.md) |
| Total liabilities | $bn | [10.9](/filings/0001783879-25-000049.md) | [39.2](/filings/0001783879-24-000145.md) | [34.2](/filings/0001783879-24-000233.md) | [36.0](/filings/0001783879-24-000296.md) | [18.2](/filings/0001783879-26-000029.md) | [19.6](/filings/0001783879-25-000145.md) | [27.3](/filings/0001783879-25-000251.md) | [32.9](/filings/0001783879-25-000310.md) | [29.0](/filings/0001783879-26-000167.md) | [35.8](/filings/0001783879-26-000062.md) | [47.0](/filings/0001783879-26-000114.md) | [48.2](/filings/0001783879-26-000167.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001783879-26-000167.md) | not reported | not reported | [2.7](/filings/0001783879-26-000167.md) |
| Shareholders' equity | $bn | [6.7](/filings/0001783879-25-000310.md) | [6.9](/filings/0001783879-25-000251.md) | [7.1](/filings/0001783879-25-000310.md) | [7.2](/filings/0001783879-25-000310.md) | [8.0](/filings/0001783879-25-000310.md) | [8.0](/filings/0001783879-25-000251.md) | [8.1](/filings/0001783879-25-000310.md) | [8.6](/filings/0001783879-25-000310.md) | [9.2](/filings/0001783879-26-000167.md) | [9.7](/filings/0001783879-26-000114.md) | [9.5](/filings/0001783879-26-000167.md) | [10.1](/filings/0001783879-26-000167.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [960 d](/filings/0001783879-26-000029.md) | [(623)](/filings/0001783879-25-000145.md) | [54.0 d](/filings/0001783879-25-000251.md) | [1,812 d](/filings/0001783879-25-000310.md) | [(1,400) d](/filings/0001783879-26-000029.md) | [642](/filings/0001783879-26-000062.md) | [3,509 d](/filings/0001783879-26-000114.md) | [(1,576) d](/filings/0001783879-26-000167.md) | [(937) d](/filings/0001783879-26-000029.md) | [2,038](/filings/0001783879-26-000062.md) | [720 d](/filings/0001783879-26-000114.md) | [1,225 d](/filings/0001783879-26-000167.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0001783879-26-000029.md) | [0.0](/filings/0001783879-25-000145.md) | [0.0 d](/filings/0001783879-25-000251.md) | [97.0 d](/filings/0001783879-25-000310.md) | [160 d](/filings/0001783879-26-000029.md) | [322](/filings/0001783879-26-000062.md) | [124 d](/filings/0001783879-26-000114.md) | [107 d](/filings/0001783879-26-000167.md) | [100 d](/filings/0001783879-26-000029.md) | [250](/filings/0001783879-26-000062.md) | [414 d](/filings/0001783879-26-000114.md) | [25.0 d](/filings/0001783879-26-000167.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [897](/filings/0001783879-24-000145.md) | [921](/filings/0001783879-24-000233.md) | [895](/filings/0001783879-24-000296.md) | [896](/filings/0001783879-25-000145.md) | [904](/filings/0001783879-25-000251.md) | [906](/filings/0001783879-25-000310.md) | [909](/filings/0001783879-26-000062.md) | [909](/filings/0001783879-26-000114.md) | [918](/filings/0001783879-26-000167.md) | [915](/filings/0001783879-26-000062.md) | [912](/filings/0001783879-26-000114.md) | [911](/filings/0001783879-26-000167.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 18:40 ET. No prices; not investment advice.